Table 4. Descriptive summary of UGE24 and inhibition of glucose reabsorption.

Parameter (units)		Total daily dose 5 mg		Total daily dose 15 mg
		Ertugliflozin 2.5 mg BID	Ertugliflozin 5 mg QD	Ertugliflozin 7.5 mg BID	Ertugliflozin 15 mg QD
UGE24, g	n	20	20	21	23
	Geometric mean	57.1	52.5	58.6	57.6
	%CV	31	34	28	28
Inhibition of glucose reabsorption, %	n	20	20	21	23
	Arithmetic mean	40.3	38.5	42.0	40.6
	%CV	27	29	26	26

Values are geometric mean and geometric %CV for UGE₂₄; or arithmetic mean and arithmetic %CV for inhibition of glucose reabsorption. BID = twice daily; %CV = percent coefficient of variation; n = number of subjects contributing to the summary statistics; QD = once daily; UGE₂₄ = urinary glucose excretion over 24 hours.